September 26, 2024
Oxford Drug Design gets a share of a £3 million Collaborative Discovery Programme
Oxford Drug Design is among the first three companies to be awarded a share of a £3 million Collaborative Discovery Programme (CDP) announced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate.